So Sarah, Aw Laraine, Sud Kamal, Lee Vincent W
Department of Renal Medicine, Westmead Hospital, Westmead, New South Wales, Australia.
University of Sydney Medical School, Sydney, New South Wales, Australia.
Nephrology (Carlton). 2018 Jul;23(7):633-639. doi: 10.1111/nep.13063.
The aim of this study is to determine whether peritoneal membrane transport status (MTS) is associated with peritonitis or poor peritoneal dialysis-related outcomes.
This retrospective cohort study analysed data of incident adult patients on peritoneal dialysis in Western Sydney between 1 October 2003 and 31 December 2012. Only patients who underwent peritoneal equilibration and adequacy tests within 6 months of commencement were included. Kaplan-Meier survival curves for time until first peritonitis and time until composite endpoint of peritonitis, death or technique failure, censored for transplant, were constructed.
About 397 patients, mean age 58.8(+/-2SD29) years, body mass index (BMI) 26.6(+/-5) kg/m and serum albumin 35.4(+/-5) g/L were included. About 59.2% had high/high-average peritoneal MTS; 45.8% were past and current smokers; 51.9% developed at least one episode of peritonitis; 7.6% changed to haemodialysis; 6.3% underwent transplantation; 8.8% died; and 25.4% remained free of the aforementioned events over a mean follow-up period of 22.5 months (range 0-115 months). Peritoneal MTS was not associated with time to first peritonitis (p = 0.67) or composite endpoint of peritonitis, death or technique failure (p = 0.12). Smoking and hypoalbuminaemia independently predicted time to first peritonitis. Past and current smokers had a hazard ratio of 1.38 (95% CI 1.03-1.86) for shorter time to first peritonitis, significant after adjustment for serum albumin (p = 0.033). Serum albumin <32 g/L had a hazard ratio of 1.74 (95% CI 1.13-2.67) for shorter time to first peritonitis, significant after adjusting for smoking (p = 0.012).
Smoking and hypoalbuminaemia, but not MTS, were associated with shorter time to first peritonitis and composite endpoint of peritonitis, death and technique failure.
本研究旨在确定腹膜转运状态(MTS)是否与腹膜炎或不良腹膜透析相关结局有关。
这项回顾性队列研究分析了2003年10月1日至2012年12月31日期间悉尼西部成年腹膜透析初治患者的数据。仅纳入开始透析后6个月内进行腹膜平衡和充分性测试的患者。构建了直至首次发生腹膜炎的时间以及直至腹膜炎、死亡或技术失败的复合终点的时间的Kaplan-Meier生存曲线,并对移植进行了删失处理。
共纳入约397例患者,平均年龄58.8(±2标准差29)岁,体重指数(BMI)26.6(±5)kg/m²,血清白蛋白35.4(±5)g/L。约59.2%的患者腹膜MTS为高/高平均水平;45.8%为既往或当前吸烟者;51.9%发生至少一次腹膜炎;7.6%转为血液透析;6.3%接受了移植;8.8%死亡;在平均22.5个月(范围0 - 115个月)的随访期内,25.4%未发生上述事件。腹膜MTS与首次发生腹膜炎的时间(p = 0.67)或腹膜炎、死亡或技术失败的复合终点时间(p = 0.12)无关。吸烟和低白蛋白血症可独立预测首次发生腹膜炎的时间。既往和当前吸烟者首次发生腹膜炎时间较短的风险比为1.38(95%可信区间1.03 - 1.86),在调整血清白蛋白后具有统计学意义(p = 0.033)。血清白蛋白<32 g/L时首次发生腹膜炎时间较短的风险比为1.74(95%可信区间1.13 - 2.67),在调整吸烟因素后具有统计学意义(p = 0.012)。
吸烟和低白蛋白血症而非MTS与首次发生腹膜炎以及腹膜炎、死亡和技术失败的复合终点时间较短有关联。